| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/10/2006 | WO2005074540A3 Novel predictors of transplant rejection determined by peripheral blood gene-expression profiling |
| 08/10/2006 | WO2005067646A3 Primers and probes for the detection of hiv |
| 08/10/2006 | WO2005027962A9 4’-thionucleosides and oligomeric compounds |
| 08/10/2006 | WO2005017181A3 System for detecting polynucleotides |
| 08/10/2006 | WO2005001417A3 Crystals of hepatitis c virus polymerase and/or hepatitis c virus polymerase-like proteins and the use thereof |
| 08/10/2006 | WO2004096979A3 Methods and systems for annotating biomolecular sequences |
| 08/10/2006 | WO2004050894A3 Heart failure gene determination and therapeutic screening |
| 08/10/2006 | WO2004037848A3 Process for determining target function and identifying drug leads |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060179507 Nucleic acid encoding protein of given sequence; hydroxylation of taxoid; used in production of anti-cancer drugs paclitaxel and taxol |
| 08/10/2006 | US20060179501 Transgenic mice expressing human cd20 |
| 08/10/2006 | US20060179497 Methods to treat conditions associated with insulin signaling dysregulation |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060178841 Integrated biosensor and simulation system for diagnosis and therapy |
| 08/10/2006 | US20060178837 Computer-assisted means for assessing lifestyle risk factors |
| 08/10/2006 | US20060178568 Rapid diagnostic assay |
| 08/10/2006 | US20060178508 Method for labeling DNA and RNA |
| 08/10/2006 | US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof |
| 08/10/2006 | US20060178437 Such as systemic lupus erythematosus by administering suberoylanilide hydroxamic acid; histone deacetylase inhibitors |
| 08/10/2006 | US20060178330 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 |
| 08/10/2006 | US20060178325 nucleosides; phosphorothioate linkages |
| 08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
| 08/10/2006 | US20060178322 Methods for indentifying compounds that modulate an enzyme involved in riboflavin metabolism in a pathogenic microorganism |
| 08/10/2006 | US20060178321 Methods for indentifying compounds that modulate an enzyme involved in reductive carboxylation in a pathogenic microorganism |
| 08/10/2006 | US20060178320 Methods for indentifying compounds that modulate an enzyme involved in thiamine metabolism in a pathogenic microorganism |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178292 Methods and compositions of ecdysozoan molt inhibition |
| 08/10/2006 | US20060177945 Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| 08/10/2006 | US20060177911 Delta 4,5 glycuronidase and methods of cleaving therewith |
| 08/10/2006 | US20060177910 Delta 4,5 glycuronidase and methods of hydrolyzing therewith |
| 08/10/2006 | US20060177903 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177891 Fiber optic bio-sensor |
| 08/10/2006 | US20060177890 Rapid-response gas sensing element |
| 08/10/2006 | US20060177889 Rapid responding gas sensing element |
| 08/10/2006 | US20060177888 Method for evaluating antioxidation capability of organism sample |
| 08/10/2006 | US20060177887 Method of analyzing a protein |
| 08/10/2006 | US20060177886 Method for diagnosis of rheumatoid arthritis |
| 08/10/2006 | US20060177885 Delta 4,5 glycuronidase and methods of analyzing therewith |
| 08/10/2006 | US20060177877 Methods for identifying combinations of entities as therapeutics |
| 08/10/2006 | US20060177868 Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array |
| 08/10/2006 | US20060177867 Repair of nucleic acids for improved amplification |
| 08/10/2006 | US20060177866 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 08/10/2006 | US20060177865 Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
| 08/10/2006 | US20060177864 Methods for identifying drug combinations for the treatment of proliferative diseases |
| 08/10/2006 | US20060177863 Biallelic markers for use in constructing a high density disequilibrium map of the human genome |
| 08/10/2006 | US20060177862 Ribosome display |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177860 Genetic markers in the HLA-DQBI gene associated with an adverse hematological response to drugs |
| 08/10/2006 | US20060177859 Compositions and methods for detecting group B streptococci |
| 08/10/2006 | US20060177858 Optimized probe selection method |
| 08/10/2006 | US20060177857 Dark quenchers, probes and other conjugates incorporating the same, and their use |
| 08/10/2006 | US20060177856 Polymerase chain reaction (PCR); measuring decrease in emission and intensity from dye after hybridization; heat treatment |
| 08/10/2006 | US20060177855 Nanoparticles for manipulation of biopolymers and methods of thereof |
| 08/10/2006 | US20060177854 Hereditary hemochromatosis gene |
| 08/10/2006 | US20060177853 Antidepressant drug target |
| 08/10/2006 | US20060177852 Solid-fluid composition |
| 08/10/2006 | US20060177851 Genetic markers of schizophrenia |
| 08/10/2006 | US20060177850 Particle-based multiplex assay system with three or more assay reporters |
| 08/10/2006 | US20060177849 Nucleic acid primer set, nucleic acid probe set and method for detecting respiratory disease virus using the primer set and probe set |
| 08/10/2006 | US20060177848 Comprising detecting at least one copy of an apolipoprotein E3 (APOE3) allele in nucleic acid of the subject, wherein detection of copy of APOE3 allele in nucleic acid of subject identifies subject as having a decreased risk of developing sepsis |
| 08/10/2006 | US20060177847 Markers for metabolic syndrome obesity and insulin resistance |
| 08/10/2006 | US20060177846 Method and apparatus for design and display of primers |
| 08/10/2006 | US20060177845 UBP1 protease mutant, and its coding sequence, their application and methods of production |
| 08/10/2006 | US20060177844 Closed-system multi-stage nucleic acid amplification reactions |
| 08/10/2006 | US20060177843 Bioarray chip reaction apparatus and its manufacture |
| 08/10/2006 | US20060177842 Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification |
| 08/10/2006 | US20060177841 Low temperature linear-after-the-exponential polymerase chain reactions; amplicons; fluorescent DNA dye; quantitative analysis |
| 08/10/2006 | US20060177840 Attaching polypeptide to ends of DNA or RNA to generate doubly end-labeled polymers; free solution electrophoresis |
| 08/10/2006 | US20060177839 Method for modulating the evolution of a polypeptide encoded by a nucleic acid sequence |
| 08/10/2006 | US20060177838 evaluating bucindolol treatment for patient with heart failure; whether to administer bucindolol based on if the patient is homozygous for the Arg 389 polymorphism in the .beta.1-adrenergic receptor; bucindolol not indicated wherein the patient is a Del322-325 carrier in alpha2cAR; pharmacogenetics |
| 08/10/2006 | US20060177837 Systems and methods for identifying diagnostic indicators |
| 08/10/2006 | US20060177836 Solid phase carriers having a first functional group which reversibly binds nucleic acids and a second functional group which selectively and reversibly binds the target nucleic acid species; quality; capillary electrophoresis; nucleotide sequencing, reverse transcription cloning and gene therapy |
| 08/10/2006 | US20060177835 A dual oligonucleotide hybridization assay combining the advantages of the direct detection assays (e.g., easy quantification and minimal risk of carry-over contamination) with the specificity provided by a dual oligonucleotide hybridization assay; site-specific nuclease cleavage by a variety of enzymes |
| 08/10/2006 | US20060177833 Attaching oligonucleotide tags for purpose of carrying out parallel analytical assays (hybridization) |
| 08/10/2006 | US20060177832 Genetic analysis by sequence-specific sorting |
| 08/10/2006 | US20060177831 c-MET kinase binding proteins |
| 08/10/2006 | US20060177830 Method of detection of predisposition to emphysema in chronic obstructive pulmonary disease |
| 08/10/2006 | US20060177829 Contacting human beta-transducin repeat containing protein ( beta -TrCP) beta -TrCP1 or beta -TrCP2 with test compound and a phosphorylated cell division cycle 25A (Cdc25A) protein or a phosphorylated fragment thereof; detecting reduced binding compared to control; drug screening; anticarcinogenic agents |
| 08/10/2006 | US20060177828 Alternatively spliced isoform of mitotic centromere-associated kinesin (MCAK) |
| 08/10/2006 | US20060177827 Method computer program with program code elements and computer program product for analysing s regulatory genetic network of a cell |
| 08/10/2006 | US20060177826 Method of producing recombinant dna molecules |
| 08/10/2006 | US20060177825 Global analysis of transposable elements as molecular markers of the developmental potential of stem cells |
| 08/10/2006 | US20060177824 Salmonella detection identification |
| 08/10/2006 | US20060177823 Molecules |
| 08/10/2006 | US20060177822 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 08/10/2006 | US20060177821 Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease |
| 08/10/2006 | US20060177820 Relates to a kit for detecting and distinguishing one or more small round structure viruses (hereinafter called "SRSVs") in a specimen; SRSV detection kit comprising all antibodies against SRSV-related virus constituting peptides; human viral gastroenteritis |
| 08/10/2006 | US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery |
| 08/10/2006 | US20060177818 Multiplex real-time RT-PCR assay with a heterologous internal control system; could be performed as a one-tube assay without loss of sensitivity or specificity |
| 08/10/2006 | US20060177817 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 08/10/2006 | US20060177816 Cellular RhoGTPase activation assay |
| 08/10/2006 | US20060177815 Dielectrophoretic particle sorter |
| 08/10/2006 | US20060177814 Systemic lupus erythematosus |
| 08/10/2006 | US20060177813 Novel high-throughput screening method of drug for bioactive protein |
| 08/10/2006 | US20060177812 Method and device for manipulating samples |
| 08/10/2006 | US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177433 Treatment of alpha-galactosidase a deficiency |